Phase Angle Is a Potential Novel Early Marker for Sarcopenia and Cognitive Impairment in the General Population
PhA is a potentially novel index for detecting the risk of sarcopenia and cognitive decline in the general population.
Authors
- Noriko Satoh‐Asahara (ORCID: https://orcid.org/0000-0002-8645-3144)
- Yuiko Yamamoto (ORCID: https://orcid.org/0009-0003-6045-1444)
- Izuru Masuda (ORCID: https://orcid.org/0000-0002-5665-9782)
- Kojiro Ishii (ORCID: https://orcid.org/0000-0002-3310-9470)
- Kan Oishi (ORCID: https://orcid.org/0000-0001-5334-9730)
- Hajime Yamakage (ORCID: https://orcid.org/0000-0003-2783-6986)
- Hisashi Kato (ORCID: https://orcid.org/0000-0003-4395-8369)
- Kentaro Ikeue (ORCID: https://orcid.org/0009-0006-5896-3899)
- M. Iwasa (ORCID: https://orcid.org/0000-0001-8761-9698)
- Sayaka Kato (ORCID: https://orcid.org/0009-0007-1243-1114)
- Masashi Tanaka (ORCID: https://orcid.org/0000-0003-0719-8972)
- Megumi Kanasaki
Institutions
- Doshisha University (JP)
- Kyoto Medical Center (JP)
- Mitsubishi Kyoto Hospital (JP)
- Takeda (Japan) (JP)
Publication Details
- Journal
- Journal of Cachexia Sarcopenia and Muscle
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1002/jcsm.13820
- Citations
- 3
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 3.49
Funders
- Takeda Science Foundation
- Novo Nordisk
- Smoking Research Foundation
- Japan Diabetes Society
- Novo Nordisk Pharma
- Japan Society for the Promotion of Science